| Style | Citing Format |
|---|---|
| MLA | Edalatifard M, et al.. "Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?." European Respiratory Journal, vol. 57, no. 4, 2021, pp. -. |
| APA | Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, Rostamian A (2021). Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?. European Respiratory Journal, 57(4), -. |
| Chicago | Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, Rostamian A. "Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?." European Respiratory Journal 57, no. 4 (2021): -. |
| Harvard | Edalatifard M et al. (2021) 'Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?', European Respiratory Journal, 57(4), pp. -. |
| Vancouver | Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, et al.. Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?. European Respiratory Journal. 2021;57(4):-. |
| BibTex | @article{ author = {Edalatifard M and Akhtari M and Salehi M and Farhadi E and Jamshidi A and Mahmoudi M and Rostamian A}, title = {Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?}, journal = {European Respiratory Journal}, volume = {57}, number = {4}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Edalatifard M AU - Akhtari M AU - Salehi M AU - Farhadi E AU - Jamshidi A AU - Mahmoudi M AU - Rostamian A TI - Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19? JO - European Respiratory Journal VL - 57 IS - 4 SP - EP - PY - 2021 ER - |